New Issue Brief: Increased Use of Biosimilars Could Bring Billions in Savings for Patients, Providers, Taxpayers
July 11, 2019
Briefs, Industry Trends, Price and Costs
Biosimilars have the potential to realize billions in savings for the health care system if reforms are enacted to incent their market share to grow, according to a new issue brief issued today by the Center for Medical Economics and Innovation at the California-based, free-market think tank, the Pacific Research Institute. “Biosimilars are innovative medications that can treat patients at lower costs,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation and author of the issue brief. ...